Taken together, these findings suggest that GEBE ameliorates T2D by increasing GLUT4 expression in WAT, remodeling the gut microbiota, and modifying serum bile acid concentrations. The gene discussed is SLC2A4; the disease is type 2 diabetes mellitus.